Your Launch Team Is Misreading Your Own Data.

Launch teams build strategies on data they already have — but the data they're missing is what determines whether the launch succeeds.

Speed to Market Can Destroy Long-Term Value.

The pressure to launch fast can undermine the evidence base, the market position, and the long-term value of a product.

Approval Without Access Is Failure.

A drug can win regulatory approval and still never reach the patients who need it. Approval is not the finish line — access is.

Data Generation Is Not the Problem. Data Translation Is.

The industry generates more data than ever. The problem is that most of it never reaches the people making the decisions that matter.

The Industry Cuts Programs Too Early. And Learns Too Little.

Patient Centricity Is a Myth Without Patient Inclusion.

A patient with stage-four lung cancer drives three hours to a clinical trial site.

The visit is for a five-minute blood draw.

He drops out the same day.

It was logged as a...

Clinical Trial Design Fails in the Details. Not Science.

Clinical trial design fails in the details, not the science.

We invest billions in developing breakthrough oncology therapies, then exclude real patients because of outdated templates and operational inertia.

Silos Aren’t a Structural Problem. They’re an Incentive Problem.

A team celebrates a successful $30 million manufacturing validation campaign.